Compounds > muraglitazar
Page last updated: 2024-09-05

muraglitazar and Metabolic Syndrome

muraglitazar has been researched along with Metabolic Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiévet, C; Fruchart, JC; Staels, B1

Reviews

1 review(s) available for muraglitazar and Metabolic Syndrome

ArticleYear
PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome.
    Current opinion in pharmacology, 2006, Volume: 6, Issue:6

    Topics: Alkanesulfonates; Animals; Diabetes Mellitus, Type 2; Glycine; Humans; Metabolic Syndrome; Models, Biological; Oxazoles; Phenylpropionates; PPAR alpha; PPAR gamma

2006

Other Studies

1 other study(ies) available for muraglitazar and Metabolic Syndrome

ArticleYear
Meeting highlights. 65th annual scientific sessions of the American Diabetes Association, San Diego. Dual PPAR agonist improves glycemic control, lipids in type 2 diabetes.
    Geriatrics, 2005, Volume: 60, Issue:8

    Topics: Diabetes Mellitus, Type 2; Glycine; Humans; Hypoglycemic Agents; Metabolic Syndrome; Oxazoles; Pioglitazone; Thiazolidinediones; United States

2005